| Hyperglycemic pseudohypoxia and diabetic complications JR Williamson, K Chang, M Frangos, KS Hasan, Y Ido, T Kawamura, ... Diabetes 42 (6), 801-813, 1993 | 1529 | 1993 |
| Selective inhibition of the inducible nitric oxide synthase by aminoguanidine TP Misko, WM Moore, TP Kasten, GA Nickols, JA Corbett, RG Tilton, ... European journal of pharmacology 233 (1), 119-125, 1993 | 890 | 1993 |
| Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction JA Corbett, RG Tilton, K Chang, KS Hasan, Y Ido, JL Wang, ... Diabetes 41 (4), 552-556, 1992 | 824 | 1992 |
| Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes AS De Vriese, RG Tilton, M Elger, CC Stephan, W Kriz, NH Lameire Journal of the American Society of Nephrology 12 (5), 993-1000, 2001 | 667 | 2001 |
| An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice BC Tieu, C Lee, H Sun, W LeJeune, A Recinos, X Ju, H Spratt, DC Guo, ... The Journal of clinical investigation 119 (12), 3637-3651, 2009 | 528 | 2009 |
| Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. AH Cross, TP Misko, RF Lin, WF Hickey, JL Trotter, RG Tilton The Journal of clinical investigation 93 (6), 2684-2690, 1994 | 483 | 1994 |
| Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion CH Yeh, L Sturgis, J Haidacher, XN Zhang, SJ Sherwood, RJ Bjercke, ... Diabetes 50 (6), 1495-1504, 2001 | 470 | 2001 |
| Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody A Flyvbjerg, F Dagnæs-Hansen, AS De Vriese, BF Schrijvers, RG Tilton, ... Diabetes 51 (10), 3090-3094, 2002 | 421 | 2002 |
| Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation RG Tilton, K Chang, KS Hasan, SR Smith, JM Petrash, TP Misko, ... Diabetes 42 (2), 221-232, 1993 | 419 | 1993 |
| Production of stem cells with embryonic characteristics from human umbilical cord blood CP McGuckin, N Forraz, MO Baradez, S Navran, J Zhao, R Urban, ... Cell proliferation 38 (4), 245-255, 2005 | 321 | 2005 |
| Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine) 536 phosphorylation Y Zhao, S Banerjee, N Dey, WS LeJeune, PS Sarkar, R Brobey, ... Diabetes 60 (7), 1907-1916, 2011 | 275 | 2011 |
| Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors RG Tilton, K Chang, G Pugliese, DM Eades, MA Province, WR Sherman, ... Diabetes 38 (10), 1258-1270, 1989 | 264 | 1989 |
| Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice A Flyvbjerg, L Denner, BF Schrijvers, RG Tilton, TH Mogensen, ... Diabetes 53 (1), 166-172, 2004 | 262 | 2004 |
| Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. NK Worrall, WD Lazenby, TP Misko, TS Lin, CP Rodi, PT Manning, ... The Journal of experimental medicine 181 (1), 63-70, 1995 | 249 | 1995 |
| Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. RG Tilton, T Kawamura, KC Chang, Y Ido, RJ Bjercke, CC Stephan, ... The Journal of clinical investigation 99 (9), 2192-2202, 1997 | 240 | 1997 |
| Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. G Pugliese, RG Tilton, JR Williamson | 232 | 1991 |
| Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. RG Tilton, KC Chang, WS Lejeune, CC Stephan, TA Brock, JR Williamson Investigative ophthalmology & visual science 40 (3), 689-696, 1999 | 210 | 1999 |
| Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes: prevention by aldose reductase inhibitors … JR Williamson, K Chang, RG Tilton, C Prater, JR Jeffrey, C Weigel, ... Diabetes 36 (7), 813-821, 1987 | 210 | 1987 |
| Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane ANS DE VRIESE, RG Tilton, CC Stephan, NH Lameire Journal of the American Society of Nephrology 12 (8), 1734-1741, 2001 | 202 | 2001 |
| Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozocin-induced diabetic rats RG Tilton, K Chang, JR Nyengaard, MV Enden, Y Ido, JR Williamson Diabetes 44 (2), 234-242, 1995 | 199 | 1995 |